Active ingredient description

Anecortave, a synthetic cortisone, has been shown to have antiangiogenic properties that have been established in multiple experimental models of angiogenesis. Anecortave is under investigation to treat exudative age-related macular degeneration (AMD). Although similar in chemical structure to the corticosteroid hydrocortisone acetate, it possesses no glucocorticoid activity.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
S Sensory organs → S01 Ophthalmologicals → S01L Ocular vascular disorder agents → S01LA Antineovascularisation agents
Discover more medicines within S01LA02


Anecortave is the active ingredient of these drugs:


South Africa

Structural formula

Graphic representation of the active ingredient's molecular structure

Chemical formula: C₂₃H₃₀O₅
Molecular mass: 344.451 g/mol

External identifiers

CAS Substance: 10184-70-0
CAS Substance: 7753-60-8
DrugBank Drug: DB12081
KEGG Drug: D01733
PubChem Compound: 7074810
UNII Identifier: R5Y8O51589